BR9509236A - Compostos purina e guanina como inibidores de pnp - Google Patents

Compostos purina e guanina como inibidores de pnp

Info

Publication number
BR9509236A
BR9509236A BR9509236A BR9509236A BR9509236A BR 9509236 A BR9509236 A BR 9509236A BR 9509236 A BR9509236 A BR 9509236A BR 9509236 A BR9509236 A BR 9509236A BR 9509236 A BR9509236 A BR 9509236A
Authority
BR
Brazil
Prior art keywords
purine
pnp inhibitors
guanine compounds
guanine
compounds
Prior art date
Application number
BR9509236A
Other languages
English (en)
Inventor
Steven Collin Beasley
Alan Findlay Haughan
John Montana
Robert John Watson
Original Assignee
Chiroscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9420127A external-priority patent/GB9420127D0/en
Priority claimed from GB9420093A external-priority patent/GB9420093D0/en
Priority claimed from GB9420045A external-priority patent/GB9420045D0/en
Application filed by Chiroscience Ltd filed Critical Chiroscience Ltd
Publication of BR9509236A publication Critical patent/BR9509236A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BR9509236A 1994-10-05 1995-10-05 Compostos purina e guanina como inibidores de pnp BR9509236A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9420127A GB9420127D0 (en) 1994-10-05 1994-10-05 Compounds
GB9420093A GB9420093D0 (en) 1994-10-05 1994-10-05 Compounds
GB9420045A GB9420045D0 (en) 1994-10-05 1994-10-05 Compounds
PCT/GB1995/002363 WO1996011200A1 (en) 1994-10-05 1995-10-05 Purine and guanine compounds as inhibitors of pnp

Publications (1)

Publication Number Publication Date
BR9509236A true BR9509236A (pt) 1997-10-21

Family

ID=27267411

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9509236A BR9509236A (pt) 1994-10-05 1995-10-05 Compostos purina e guanina como inibidores de pnp

Country Status (14)

Country Link
US (1) US5736549A (pt)
EP (1) EP0784624A1 (pt)
JP (1) JPH10507171A (pt)
CN (1) CN1045088C (pt)
AU (1) AU695032B2 (pt)
BR (1) BR9509236A (pt)
CA (1) CA2201773A1 (pt)
CZ (1) CZ99797A3 (pt)
FI (1) FI971413A0 (pt)
HU (1) HUT77436A (pt)
MX (1) MX9702488A (pt)
NO (1) NO971538L (pt)
PL (1) PL319485A1 (pt)
WO (1) WO1996011200A1 (pt)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9510327A (pt) * 1994-10-22 1998-11-10 Chong Kun Dang Corp Derivados de nucleosídeos e seu processo de preparo
CN1501928A (zh) * 2000-11-02 2004-06-02 斯隆-凯特林癌症研究所 结合hsp90的小分子组合物
AU2003233667A1 (en) * 2002-05-23 2003-12-12 Biocryst Pharmaceuticals, Inc. Enhancing the efficacy of reverse transcriptase and dna polymerase inhibitors (nucleoside analogs) using pnp inhibitors and/or 2'-deoxyguanosine and/or prodrug thereof
DK1539783T3 (da) * 2002-08-21 2011-06-20 Einstein Coll Med Inhibitorer af nucleosidphosphorylaser og nucleosidaser
US20070219178A1 (en) * 2003-12-04 2007-09-20 Eisai Co., Ltd. Preventive or therapeutic agents for multiple sclerosis
ES2563952T3 (es) 2004-03-26 2016-03-16 Sumitomo Dainippon Pharma Co., Ltd. Compuesto de 8-oxoadenina 9-sustituido
US20110104186A1 (en) 2004-06-24 2011-05-05 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
TW200801003A (en) * 2005-09-16 2008-01-01 Astrazeneca Ab Novel compounds
TW200745114A (en) * 2005-09-22 2007-12-16 Astrazeneca Ab Novel compounds
US20090192153A1 (en) * 2005-09-22 2009-07-30 Dainippon Sumitomo Pharma Co., Ltd. a corporation of Japan Novel adenine compound
WO2007034817A1 (ja) * 2005-09-22 2007-03-29 Dainippon Sumitomo Pharma Co., Ltd. 新規アデニン化合物
JPWO2007034882A1 (ja) * 2005-09-22 2009-03-26 大日本住友製薬株式会社 新規アデニン化合物
EP1939200A4 (en) * 2005-09-22 2010-06-16 Dainippon Sumitomo Pharma Co NEW ADENINE CONNECTION
EP1975149B1 (en) 2005-12-26 2012-02-15 Nissan Chemical Industries, Ltd. 1,3-bis(substituted phenyl)-3-hydroxypropan-1-one or 2-propen-1-one compound, and salt thereof
EP2041135A4 (en) * 2006-07-05 2010-12-01 Astrazeneca Ab As TLR7 MODULATORS, 8-OXOADENINE DERIVATIVES WORK
TW200831105A (en) * 2006-12-14 2008-08-01 Astrazeneca Ab Novel compounds
JP5329444B2 (ja) * 2007-03-19 2013-10-30 アストラゼネカ・アクチエボラーグ Toll様受容体(tlr7)モジュレーターとしての9−置換−8−オキソ−アデニン化合物
JP5480637B2 (ja) * 2007-03-19 2014-04-23 アストラゼネカ・アクチエボラーグ Toll様受容体(tlr7)モジュレーターとしての9−置換−8−オキソ−アデニン化合物
PE20081887A1 (es) * 2007-03-20 2009-01-16 Dainippon Sumitomo Pharma Co Nuevo compuesto de adenina
EP2138497A4 (en) * 2007-03-20 2012-01-04 Dainippon Sumitomo Pharma Co NEW ADENINE CONNECTION
US8436178B2 (en) * 2007-05-08 2013-05-07 Astrazeneca Ab Imidazoquinolines with immuno-modulating properties
PE20091236A1 (es) * 2007-11-22 2009-09-16 Astrazeneca Ab Derivados de pirimidina como immunomoduladores de tlr7
UA104579C2 (uk) * 2007-12-10 2014-02-25 Байокрист Фармасьютикалз, Инк. Спосіб лікування раку кровотворної системи із застосуванням фородезину у комбінації з ритуксимабом
UY31531A1 (es) 2007-12-17 2009-08-03 Sales derivadas de 8-oxoadenina composiciones farmacéuticas que las contienen y su uso en terapia como moduladores de receptor tipo toll (tlr)
EP2246353A4 (en) 2008-01-17 2011-04-20 Dainippon Sumitomo Pharma Co PROCESS FOR PREPARING AN ADENINE COMPOUND
JPWO2009091031A1 (ja) * 2008-01-17 2011-05-26 大日本住友製薬株式会社 アデニン化合物の製造方法
GB0908772D0 (en) * 2009-05-21 2009-07-01 Astrazeneca Ab New salts 756
WO2010133885A1 (en) 2009-05-21 2010-11-25 Astrazeneca Ab Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases
WO2011068233A1 (en) * 2009-12-03 2011-06-09 Dainippon Sumitomo Pharma Co., Ltd. Imidazoquinolines which act via toll - like receptors (tlr)
JP5978225B2 (ja) 2010-12-16 2016-08-24 大日本住友製薬株式会社 治療に有用なイミダゾ[4,5−c]キノリン−1−イル誘導体
EP2651943B1 (en) 2010-12-17 2017-03-22 Sumitomo Dainippon Pharma Co., Ltd. Purine derivatives
KR101708761B1 (ko) * 2012-04-13 2017-02-21 주식회사 머쉬메드 퓨린 유도체 또는 그의 염을 포함하는 아토피성 피부염의 예방 또는 치료용 조성물
CA2871589C (en) 2012-05-18 2020-12-22 Seiji Hori Pyrimidine carboxylic acid derivatives and their use as tlr7 agonists

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241063A (en) * 1979-08-06 1980-12-23 Bristol-Myers Company Purine derivatives and their use as bronchodilators
FI802401A (fi) * 1979-08-06 1981-02-07 Bristol Myers Co Bronkutvidgande purin
US4748177A (en) * 1984-03-26 1988-05-31 Warner-Lambert Company Guanine derivatives
EP0182024B1 (en) * 1984-09-20 1991-04-03 Beecham Group Plc Purine derivatives and their pharmaceutical use
IL76546A (en) * 1984-10-12 1988-12-30 Warner Lambert Co 9-(heteroarylalkyl)-6-purine(thi)one derivatives,their preparation and pharmaceutical compositions containing them
EP0193454A1 (en) * 1985-02-25 1986-09-03 Merck & Co. Inc. 8-Substituted-9-hydroxyalkyl and hydroxyalkoxymethyl-guanines and pharmaceutical compositions containing them
CA1293727C (en) * 1986-08-26 1991-12-31 Catherine Rose Kostlan 9-deazaguanines
EP0302644B1 (en) * 1987-08-01 1997-01-29 Beecham Group Plc Purine compounds and their preparation
US4996308A (en) * 1988-03-25 1991-02-26 Merrell Dow Pharmaceuticals Inc. Derivatives with unsaturated substitutions for the 5'-hydroxymethyl group
WO1991006548A1 (en) * 1989-10-31 1991-05-16 Biocryst, Inc. Inhibitors of purine nucleoside phosphorylase
US4985434A (en) * 1989-10-31 1991-01-15 Biocryst, Inc. 7-substituted derivatives of 2-amino-3H,5H-pyrrolo(3,2-d)pyrimidin-4-ones and pharamceutical uses and compositions containing the same
NL9300058A (nl) * 1992-06-18 1994-01-17 Stichting Rega V Z W 1,5-anhydrohexitol nucleoside analoga en farmaceutisch gebruik daarvan.
US5314893A (en) * 1993-01-25 1994-05-24 Bristol-Myers Squibb Co. Antiviral tetrahydropyrans
WO1995022330A1 (en) * 1994-02-17 1995-08-24 Commonwealth Scientific And Industrial Research Organisation Antiviral agents

Also Published As

Publication number Publication date
WO1996011200A1 (en) 1996-04-18
EP0784624A1 (en) 1997-07-23
CN1045088C (zh) 1999-09-15
FI971413A (fi) 1997-04-04
NO971538L (no) 1997-06-04
CA2201773A1 (en) 1996-04-18
JPH10507171A (ja) 1998-07-14
HUT77436A (hu) 1998-04-28
AU3612895A (en) 1996-05-02
NO971538D0 (no) 1997-04-04
AU695032B2 (en) 1998-08-06
PL319485A1 (en) 1997-08-04
CN1160402A (zh) 1997-09-24
US5736549A (en) 1998-04-07
MX9702488A (es) 1998-04-30
CZ99797A3 (en) 1997-09-17
FI971413A0 (fi) 1997-04-04

Similar Documents

Publication Publication Date Title
BR9509236A (pt) Compostos purina e guanina como inibidores de pnp
BR9709643A (pt) Compostos antivirais
NO973326D0 (no) Guaninderivater
DE69515355D1 (de) Mehrfacharbitrierungsschema
DE29611736U1 (de) Kugelschreiber
ID19490A (id) Kombinasi-kombinasi antiviral
FI953127A0 (fi) Puriinijohdannaisia
NO992103L (no) Dihydropyroner med forbedret antiviral aktivitet
FI943744A0 (fi) Hopfaellbart staell foer baerbar mikrodator i bil
BR9709432A (pt) Composto antivirais
DE69528623T2 (de) Leitgerät
BR9709528A (pt) Compostos antivirais
DE69501440T2 (de) Schreiberhalterung
BR9510418A (pt) Derivados tienoxazinona úteis como agentes antivirais
FI964468A (fi) Adenosiinijohdannaisia
ID18739A (id) Kombinasi-kombinasi antiviral
KR970018486U (ko) 냉각펜
DE29708468U1 (de) Werkzeug-Gestell
DE29617672U1 (de) Schreibstift
KR960004335U (ko) 펜촉
DE29600851U1 (de) Schreibstift
DE29618934U1 (de) Kugelschreiber
DE29605613U1 (de) Fingerschreibgerät
SE9600614D0 (sv) Antiviral compounds
SE9602566D0 (sv) Antiviral compounds

Legal Events

Date Code Title Description
TC Change of name
PC Transfer

Free format text: DARWIN DISCOVERY LIMITED (GB)

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements